The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2–dependent manner
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Changes of the microtubule-associated protein tau are central in Alzheimer’s disease (AD) and frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17). However, the functional consequence of the FTDP-17 tau mutation R406W, which causes a tauopathy clinically resembling AD, is not well understood. We find that the R406W mutation does not affect microtubule interaction but abolishes tau’s membrane binding. Loss of binding is associated with decreased trapping at the tip of neurites and increased length fluctuations during process growth. Tandem affinity purification tag purification and mass spectrometry identify the calcium-regulated plasma membrane–binding protein annexin A2 (AnxA2) as a potential interaction partner of tau. Consistently, wild-type tau but not R406W tau interacts with AnxA2 in a heterologous yeast expression system. Sequestration of Ca2+ or knockdown of AnxA2 abolishes the differential trapping of wild-type and R406W tau. We suggest that the pathological effect of the R406W mutation is caused by impaired membrane binding, which involves a functional interaction with AnxA2 as a membrane–cytoskeleton linker.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Annexins: From Structure to Function
Gerke, V., & Moss, S. E. (2002) · Physiological Reviews · doi:10.1152/physrev.00030.2001 · Cited by 2,029
Self-citationThe GSK3 hypothesis of Alzheimer’s disease
Hooper, C., Killick, R., & Lovestone, S. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05194.x · Cited by 1,191
Microtubules containing acetylated alpha-tubulin in mammalian cells in culture.
Piperno, G., LeDizet, M., & Chang, X. J. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.2.289 · Cited by 873 · cited 1×
“It is known that binding of tau to microtubules results in increased microtubule stability, which is manifested by a higher ratio of acetylated/total tubulin (Piperno et al., 1987).”
Biernat, J., Gustke, N., Drewes, G., Mandelkow, E., & Mandelkow, E. (1993) · Neuron · doi:10.1016/0896-6273(93)90279-z · Cited by 796
Self-citationAnimal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676 · cited 1×
“All of these features have also been reported in AD mouse models (Götz and Ittner, 2008).”
β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595
Global Hairpin Folding of Tau in Solution
Jeganathan, S., von Bergen, M., Brutlach, H., Steinhoff, H.-J., & Mandelkow, E. (2006) · Biochemistry · doi:10.1021/bi0521543 · Cited by 432 · cited 1×
“However, it has been shown previously that tau can adopt a “paperclip” conformation, in which the amino- and carboxy-terminal domains approach each other (Jeganathan et al., 2006).”
Maas, T., Eidenmüller, J., & Brandt, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000389200 · Cited by 226 · cited 7×
“Microsphere separation of the membrane cortex Microsphere separation of the neural membrane cortex was performed from PC12 cells stably expressing wt tau or R406W tau as described previously (Maas et al., 2000).”
InfluentialSelf-citationTackenberg, C., & Brandt, R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3590-09.2009 · Cited by 127 · cited 3×
“In AD, it has been shown that pathologically increased amounts of amyloid (A), a cleavage product of the amyloid precursor protein (APP), trigger an increased phosphorylation of tau (Busciglio et al., 1995; Leschik et al., 2007; Tackenberg and Brandt, 2009).”
Self-citation
Research works printed but not linked: 42
- Aoyagi, 2007, Fibrillogenic nuclei composed of P301L mutant tau induce elongation of P301L tau but not wild-type tau, J. Biol. Chem., 282, 20309, 10.1074/jbc.M611876200 · DOI · Paper page
- Brajenovic, 2004, Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network, J. Biol. Chem., 279, 12804, 10.1074/jbc.M312171200 · DOI · Paper page
- Brandt, 1995, Interaction of tau with the neural plasma membrane mediated by tau’s amino-terminal projection domain, J. Cell Biol., 131, 1327, 10.1083/jcb.131.5.1327 · DOI · Paper page
- Bunker, 2006, FTDP-17 mutations compromise the ability of tau to regulate microtubule dynamics in cells, J. Biol. Chem., 281, 11856, 10.1074/jbc.M509420200 · DOI · Paper page
- Chang, 2008, Pathogenic missense MAPT mutations differentially modulate tau aggregation propensity at nucleation and extension steps, J. Neurochem., 107, 1113, 10.1111/j.1471-4159.2008.05692.x · DOI · Paper page
- Connell, 2001, Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes, FEBS Lett., 493, 40, 10.1016/S0014-5793(01)02267-0 · DOI · Paper page
- Cruz, 2004, Cdk5 deregulation in the pathogenesis of Alzheimer’s disease, Trends Mol. Med., 10, 452, 10.1016/j.molmed.2004.07.001 · DOI · Paper page
- Dayanandan, 1999, Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation, FEBS Lett., 446, 228, 10.1016/S0014-5793(99)00222-7 · DOI · Paper page
- DeTure, 2000, Missense tau mutations identified in FTDP-17 have a small effect on tau-microtubule interactions, Brain Res., 853, 5, 10.1016/S0006-8993(99)02124-1 · DOI
- DeTure, 2002, Tau assembly in inducible transfectants expressing wild-type or FTDP-17 tau, Am. J. Pathol., 161, 1711, 10.1016/S0002-9440(10)64448-3 · DOI
- Dittgen, 2004, Lentivirus-based genetic manipulations of cortical neurons and their optical and electrophysiological monitoring in vivo, Proc. Natl. Acad. Sci. USA., 101, 18206, 10.1073/pnas.0407976101 · DOI · Paper page
- Drubin, 1988, Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells, J. Cell Biol., 106, 1583, 10.1083/jcb.106.5.1583 · DOI · Paper page
- Eberhard, 1994, Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus, Am. J. Pathol., 145, 640
- Eidenmüller, 2001, Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein, Biochem. J., 357, 759, 10.1042/0264-6021:3570759 · doi:10.1042/0264-6021:3570759 · Paper page
- Fath, 2002, Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer’s disease, J. Neurosci., 22, 9733, 10.1523/JNEUROSCI.22-22-09733.2002 · DOI · Paper page
- Foster, 1997, Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference, Ann. Neurol., 41, 706, 10.1002/ana.410410606 · DOI · Paper page
- Fox, 1991, Increases in p11 and annexin II proteins correlate with differentiation in the PC12 pheochromocytoma, Biochem. Biophys. Res. Commun., 177, 1188, 10.1016/0006-291X(91)90666-U · doi:10.1016/0006-291x(91)90666-u
- Gerke, 1997, Annexins and membrane dynamics, Biochim. Biophys. Acta., 1357, 129, 10.1016/S0167-4889(97)00038-4 · DOI · Paper page
- Gerke, 2005, Annexins: linking Ca2+ signalling to membrane dynamics, Nat. Rev. Mol. Cell Biol., 6, 449, 10.1038/nrm1661 · DOI · Paper page
- Ikeuchi, 2008, Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations, Dement. Geriatr. Cogn. Disord., 26, 43, 10.1159/000141483 · DOI
- Jacovina, 2001, Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation, J. Biol. Chem., 276, 49350, 10.1074/jbc.M106289200 · DOI
- Kirchrath, 2000, Comparative genetic and physiological studies of the MAP kinase Mpk1p from Kluyveromyces lactis and Saccharomyces cerevisiae, J. Mol. Biol., 300, 743, 10.1006/jmbi.2000.3916 · DOI
- Krishnamurthy, 2004, Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model, J. Biol. Chem., 279, 7893, 10.1074/jbc.M311203200 · DOI · Paper page
- Leschik, 2007, Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death, J. Neurochem., 101, 1303, 10.1111/j.1471-4159.2006.04435.x · DOI · Paper page
- Leugers, 2010, Tau potentiates nerve growth factor-induced mitogen-activated protein kinase signaling and neurite initiation without a requirement for microtubule binding, J. Biol. Chem., 285, 19125, 10.1074/jbc.M110.105387 · DOI · Paper page
- Lindquist, 2008, Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation, Eur. J. Neurol., 15, 377, 10.1111/j.1468-1331.2008.02069.x · DOI · Paper page
- Matsumura, 1999, Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), Am. J. Pathol., 154, 1649, 10.1016/S0002-9440(10)65420-X · DOI
- Miyasaka, 2001, Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation, Am. J. Pathol., 158, 373, 10.1016/S0002-9440(10)63979-X · DOI
- Morgan, 1997, Annexin gene structures and molecular evolutionary genetics, Cell. Mol. Life Sci., 53, 508, 10.1007/s000180050064 · DOI
- Ostojic, 2004, The tau R406W mutation causes progressive presenile dementia with bitemporal atrophy, Dement. Geriatr. Cogn. Disord., 17, 298, 10.1159/000077158 · DOI · Paper page
- Patterson, 2002, A photoactivatable GFP for selective photolabeling of proteins and cells, Science., 297, 1873, 10.1126/science.1074952 · DOI · Paper page
- Rescher, 2004, Annexins—unique membrane binding proteins with diverse functions, J. Cell Sci., 117, 2631, 10.1242/jcs.01245 · DOI · Paper page
- Rizzu, 1999, High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands, Am. J. Hum. Genet., 64, 414, 10.1086/302256 · DOI · Paper page
- Schlaepfer, 1990, Expression of annexins as a function of cellular growth state, J. Cell Biol., 111, 229, 10.1083/jcb.111.1.229 · DOI
- Spillantini, 1996, Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles, Acta Neuropathol., 92, 42, 10.1007/s004010050487 · DOI · Paper page
- Sprague, 2004, Analysis of binding reactions by fluorescence recovery after photobleaching, Biophys. J., 86, 3473, 10.1529/biophysj.103.026765 · DOI · Paper page
- Stoothoff, 2005, Tau phosphorylation: physiological and pathological consequences, Biochim. Biophys. Acta., 1739, 280, 10.1016/j.bbadis.2004.06.017 · DOI · Paper page
- Thiel, 1992, The tight association of the tyrosine kinase substrate annexin II with the submembranous cytoskeleton depends on intact p11- and Ca(2+)-binding sites, J. Cell Sci., 103, 733, 10.1242/jcs.103.3.733 · DOI · Paper page
- Vogelsberg-Ragaglia, 2000, Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells, Mol. Biol. Cell., 11, 4093, 10.1091/mbc.11.12.4093 · DOI · Paper page
- Weissmann, 2009, Microtubule binding and trapping at the tip of neurites regulate tau motion in living neurons, Traffic., 10, 1655, 10.1111/j.1600-0854.2009.00977.x · DOI · Paper page
- Yoshiyama, 2001, Frontotemporal dementia and tauopathy, Curr. Neurol. Neurosci. Rep., 1, 413, 10.1007/s11910-001-0100-0 · DOI
- Zhang, 2004, Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy, J. Neurosci., 24, 4657, 10.1523/JNEUROSCI.0797-04.2004 · DOI · Paper page
Cited by
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration
Mandelkow, E.-M., & Mandelkow, E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006247 · Cited by 847
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609
Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration
Tracy, T. E., Madero-Pérez, J., Swaney, D. L., Chang, T. S., Moritz, M., Konrad, C., Ward, M. E., Stevenson, E., Hüttenhain, R., Kauwe, G., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.041 · Cited by 342
Dendritic Tau in Alzheimer’s Disease
Ittner, A., & Ittner, L. M. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.003 · Cited by 278
Metadata
- Authors
- Gauthier-Kemper, A., Weissmann, C., Golovyashkina, N., Sebö-Lemke, Z., Drewes, G., Gerke, V., Heinisch, J. J., & Brandt, R.
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2011-02-21
- Volume
- 192
- Issue
- 4
- Pages
- 647-661
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2146107198
- Cited by
- 136
- References
- 9
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2–dependent manner. https://app.cochat.ai/papers/10.1083/jcb.201007161
- The paper
- Gauthier-Kemper, A., Weissmann, C., Golovyashkina, N., Sebö-Lemke, Z., Drewes, G., Gerke, V., Heinisch, J. J., & Brandt, R. (2011). The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2–dependent manner. Journal of Cell Biology. https://doi.org/10.1083/jcb.201007161
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.